Cybin Inc. (HELP)
Nasdaq: HELP · Pharmaceutical Preparations · Toronto, ON · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in March.The Form 40-F filed Jun 29, 2026 for the period ended Mar 31, 2026 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Period ending | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 |
| Report filed | Jun 29, 2026 | Jul 1, 2025 | Jun 26, 2024 |
| Research and development | 86,588 | 39,211 | · |
| General and administrative | 45,136 | 32,632 | · |
| Total operating expenses | 142,587 | 103,125 | · |
| Interest income | 5,100 | 5,990 | · |
| Net income | -147,998 | -81,607 | · |
| Earnings per share, basic | -4.25 | -4.04 | · |
| Earnings per share, diluted | -4.25 | -4.04 | · |
| Weighted average shares, basic | 34,802,943 | 20,222,493 | 8,297,370r |
| Weighted average shares, diluted | 34,802,943 | 20,222,493 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-38 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
ifrs-full:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
ifrs-full:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
ifrs-full:OperatingExpenseInterest income what its cash and investments earned
ifrs-full:RevenueFromInterestNet income the whole group's profit, minority holders' share included
ifrs-full:ProfitLossEarnings per share, basic net income per share outstanding
ifrs-full:BasicEarningsLossPerShareEarnings per share, diluted net income per share, counting every share that could be issued
ifrs-full:DilutedEarningsLossPerShareWeighted average shares, basic the average count of shares outstanding
ifrs-full:WeightedAverageSharesWeighted average shares, diluted the average count with every share that could be issued
ifrs-full:AdjustedWeightedAverageShares